Factors associated with the clinical outcome of patients with relapsed/refractory CD19 + acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy.

Valentín Ortiz-MaldonadoSusana RivesMarta Español-RegoAnna Alonso-SaladriguesMercedes MontoroLaura MagnanoEva GinéMariona PascalMarina Díaz-BeyáMaria CastellaAlbert CatalàAnna FauraLuis Gerardo Rodríguez-LobatoMarta GarroteAlexandra Martínez-RocaMontserrat RoviraE Azucena González-NavarroJuan Ramón OrtegaJoan CidMiquel LozanoEnric Garcia-ReySara FernándezPedro CastroIolanda JordanNeus VillamorMarta AymerichMontserrat TorrebadellÀngela DeyàCarlos Fernández de LarreaDaniel Benitez-RibasEsteve TriasSara VareaGonzalo CalvoJordi EsteveAlvaro Urbano-IspizuaManel Juan Julio Delgado

Published in: Journal for immunotherapy of cancer (2022)

Keyphrases

cell therapy
acute lymphoblastic leukemia
stem cells
allogeneic hematopoietic stem cell transplantation
mesenchymal stem cells
nk cells
newly diagnosed
diffuse large b cell lymphoma
hodgkin lymphoma
multiple myeloma